Related by context. All words. (Click for frequent words.) 74 SNP rs# [001] 73 rs# [004] 70 PTPN# 70 rs# [002] 69 rs# [003] 69 hypermethylated 68 ALB # 68 heterozygotes 68 ZNF# 68 DNMT1 68 protein tyrosine phosphatase 68 Multivariate analysis 68 thyrotropin 68 CDKN2A 68 multivariable analysis 68 GSTP1 67 chromosome #q# [002] 67 Microarray analysis 67 IL#B 67 Univariate analysis 67 allelic variants 67 multivariate analyzes 67 hepatic lipase 67 C#Y 67 prostate cancer CaP 67 ABCB1 67 GLUT1 67 RRM1 67 cytokeratin 67 HepG2 cells 67 chromosome #q# [001] 67 rs# [001] 67 chromosome #p#.# 67 LRP5 66 coexpression 66 ERalpha 66 cagA 66 CagA 66 tumorigenicity 66 KIAA# 66 COL#A# 66 MECP2 gene 66 Immunohistochemical staining 66 Clusterin 66 gene polymorphism 66 hepatoma 66 ERBB2 66 Immunohistochemical analysis 66 genetic loci 66 gene polymorphisms 66 epithelial tumors 66 immunohistochemical 66 K ras mutations 66 MTHFR 66 mRNA expression 66 immunoreactivity 66 Subgroup analysis 66 intronic 66 clinicopathological 66 paternally inherited 65 SSc 65 germline mutations 65 TT genotype 65 TCF#L# 65 prostate carcinoma 65 H#K#me# 65 airway responsiveness 65 ESR1 65 soluble CD# ligand 65 CD#c 65 TMPRSS2 ERG fusion 65 mediated inhibition 65 downregulated 65 SMAD4 65 intestinal permeability 65 catechol O methyltransferase 65 metabolomic profiles 65 EGFR expression 65 lymph node metastasis 65 prognostic significance 65 Ki# 65 MAPK pathway 65 #p# [003] 65 susceptibility loci 65 TOP2A 65 constitutively expressed 65 functional polymorphism 65 PON1 65 c MYC 65 variant allele 65 gene loci 65 PTHrP 65 AMACR 65 promoter methylation 65 constitutively active 65 Leydig cells 65 multivariate Cox 65 transgene expression 65 DRB1 * 65 microsatellite instability 65 upregulates 65 ADRB2 65 orthologs 65 PCa 65 NNRTI resistance 64 quantitative trait loci 64 HER2 neu 64 KLF4 64 Leydig cell 64 5 HTTLPR 64 GSTT1 64 transmembrane receptor 64 virulence genes 64 steroidogenic 64 MSH2 64 APOE e4 64 MLH1 64 RASSF1A 64 familial clustering 64 hypermethylation 64 variant rs# 64 missense mutations 64 glomerular 64 dysbindin 64 VKORC1 64 tumor histology 64 mutated K ras 64 hepatocellular carcinomas 64 allelic 64 HLA DRB1 64 chromosome #p# [001] 64 nodal metastasis 64 HLA DRB1 SE 64 mRNA transcripts 64 #q# [001] 64 immunohistochemical staining 64 somatic mutation 64 AST ALT 64 KIF6 gene 64 inhibin B 64 histone modifications 64 CD# expression [001] 64 gastric carcinoma 64 Apolipoprotein E 64 TIMP 1 64 FGFR2 64 vimentin 64 causal variants 64 TNF blocker therapy 64 etiologic 64 mucinous 64 FGFR3 64 monocyte chemoattractant protein 64 lymphovascular invasion 64 somatic mutations 64 HLA DRB1 * 64 genetic polymorphism 64 adiponectin concentrations 64 pDC 64 TIMP 64 uPAR 64 Cathepsin B 64 cell adhesion molecule 64 S#A# [002] 64 HGPIN 64 NAT2 64 NKX#.# 64 PON1 gene 64 intact parathyroid hormone 63 syngeneic 63 eotaxin 63 clade B 63 SLC#A# [002] 63 Rap1 63 ERK signaling 63 BRAF V#E 63 COX2 63 histone acetylation 63 NR#A# 63 methylenetetrahydrofolate reductase 63 osteoblast 63 APOE ε4 63 ORMDL3 63 APOC3 63 breast carcinomas 63 chromosome #p# [002] 63 DRD2 63 null mice 63 WT1 63 CDK4 63 susceptibility locus 63 BARD1 63 bronchial epithelial cells 63 #p# [001] 63 prognostic indicators 63 STAT4 63 FGFs 63 HMGA1 63 echocardiographic parameters 63 chemokine receptor 63 LV dysfunction 63 effector function 63 TTR gene 63 lactate dehydrogenase 63 redox active 63 Foxp3 63 airway hyperresponsiveness 63 gene locus 63 susceptibility gene 63 HER2 expression 63 colorectal adenoma 63 #ß 63 allele frequencies 63 microglial 63 #q#.# [001] 63 Multivariate analyzes 63 E#F# 63 logistic regression analysis 63 TCF#L# gene 63 prostate carcinogenesis 63 homozygosity 63 GSTM1 63 Angiotensin converting enzyme 63 genetic polymorphisms 63 BMP2 63 AGTR1 63 beta1 integrin 63 FasL 63 Subgroup analyzes 63 DNA methylation patterns 63 methylation patterns 63 ERK1 2 63 alkaline phosphatase ALP 63 esophageal squamous cell carcinoma 63 extramedullary 63 metabolizing enzyme 63 univariate analysis 63 transcriptional activation 63 histological subtype 63 DQB1 * 63 CYP#A# [002] 63 SHANK3 63 androgen receptor AR 63 CD#b 63 alpha7 63 posttranslational modifications 63 NKG2D 63 PCA3 gene 63 microvessel density 63 TGFß 63 P cadherin 63 familial aggregation 63 chromosome #q#.# [001] 63 #β HSD1 63 VEGF expression 63 metabolite concentrations 63 kidney allograft 63 thyrotropin levels 63 HLA DQ2 63 CNTNAP2 63 c KIT 63 papillary renal cell carcinoma 63 heterozygosity 63 hENT1 63 apolipoprotein B 63 serum triglycerides 63 IPAH 63 clinicopathological features 63 LPA gene 63 TNFalpha 63 serum BDNF 62 c fos 62 C#T [002] 62 isoprostane 62 FDG PET imaging 62 eosinophil count 62 IDH1 mutation 62 prognostic factor 62 proband 62 chromosomal rearrangement 62 ABL1 62 UGT#A# * 62 BRAF V#E mutation 62 carcinoembryonic antigen 62 immunohistochemical analysis 62 TOP2A gene 62 multivariate adjustment 62 C#BL/#J mice 62 splenocytes 62 serine protease 62 bronchoalveolar 62 potent inhibition 62 UGT#B# 62 atypical hyperplasia 62 DEAR1 62 Fas ligand 62 hormone receptor negative 62 urothelial 62 immunized mice 62 paricalcitol 62 astrocytic 62 PB1 F2 62 homozygotes 62 IFRD1 62 endophenotypes 62 serum leptin 62 TRAIL induced apoptosis 62 HMGCR 62 3'UTR 62 lipoxygenase 62 isoenzyme 62 TNF α 62 multiple logistic regression 62 immunoblotting 62 penetrance 62 activin 62 antibody titer 62 immunostaining 62 Upregulation 62 subcellular localization 62 GABRA2 62 prognostic marker 62 glutamic acid decarboxylase 62 #p#.# [002] 62 kDa protein 62 resistin 62 c Myb 62 transactivation 62 colorectal carcinoma 62 APOE genotype 62 haematopoietic 62 histologic subtype 62 thyroglobulin 62 anterior pituitary 62 microvessel 62 miRNA genes 62 EphB4 62 univariate 62 LHRH receptor positive 62 IKZF1 62 MSMB 62 FUS1 62 #β estradiol 62 osteoprotegerin 62 heparanase 62 downregulation 62 conserved sequences 62 immunoreactive 62 interleukin IL 62 prognostic markers 62 CD8 + 62 plasma adiponectin 62 immunodominant 62 activating mutations 62 FGF2 62 FKBP# 62 neuritic 62 t# c# CLA 62 Wwox 62 p# activation 62 lymphangiogenesis 62 gene MECP2 62 orthologous 62 PRNP 62 node metastases 62 microRNA expression 62 luciferase reporter 62 ERCC1 62 CDK8 62 cystatin C 62 differentially expressed genes 62 RhoA 62 μg ml 62 Dysregulation 62 TrkB 62 Jhdm2a 62 epistasis 62 CC genotype 62 transcriptional profiles 62 MYH9 gene 62 ENPP1 62 PITX2 62 linkage disequilibrium 62 microglial activation 62 PAX5 62 receptor kinase 62 scintigraphic 62 Eg5 62 β1 62 mononuclear 62 IFN γ 62 intergenic regions 62 LPS induced 62 JAK2 mutation 61 GPC5 61 HFE gene 61 Rb#/p# 61 miRNA expression 61 Akt activation 61 amnestic MCI 61 ventricular myocardium 61 rs# rs# 61 μmol L 61 microcephalin 61 Cx# [001] 61 polyamine 61 CCR7 61 transcriptional repressor 61 #q# deletion 61 genotypic 61 cardiac troponin T 61 proto oncogene 61 tryptase 61 BEXXAR Therapeutic Regimen 61 ADAM# 61 mitogen activated protein kinase 61 IL6 61 IGF IR 61 nondemented 61 Monocyte 61 metastatic prostate 61 hematopoietic cancers 61 histopathological 61 thyroid carcinoma 61 downstream effector 61 dose proportionality 61 somatostatin 61 VCAM 1 61 advanced adenoma 61 MYBPC3 61 seropositivity 61 E selectin 61 miR #a [001] 61 HBsAg 61 #S rRNA 61 KRAS mutations 61 #p#.# [001] 61 HOXB# 61 HER2 receptor 61 differential gene expression 61 plasma lipid 61 CEACAM1 61 nonmetastatic 61 serum concentrations 61 CALHM1 61 spirometric 61 pathophysiological effects 61 Polymorphisms 61 TGF ß 61 rRNA 61 dinucleotide 61 Kinoid 61 EF Tu 61 cytokine interleukin 61 hematological relapse 61 HER2 overexpression 61 p# INK4a 61 C. pneumoniae 61 prognostic indicator 61 GABAergic interneurons 61 perineural invasion 61 causative mutations 61 DLX5 61 MT1 MMP 61 diagnostic biomarker 61 tyrosine phosphorylation 61 virulence determinants 61 WNK1 61 advanced neoplasia 61 ribosomal protein 61 bronchoalveolar lavage fluid 61 pDCs 61 breast cancer subtypes 61 CD# CD# 61 lymph node metastases 61 histone methylation 61 hTERT 61 chromosomal aberrations 61 Prox1 61 apolipoprotein E4 61 FGFR1 61 gastric adenocarcinoma 61 HIF 1alpha 61 TGFBR1 * 6A 61 miRs 61 cytokine signaling 61 umbilical vein 61 colorectal tumor 61 hydroxylase 61 receptor inhibitor 61 mRNA encoding 61 bile acid metabolism 61 A3 adenosine receptor 61 adipogenic 61 Histologic 61 dose dependently 61 breast carcinoma 61 histone deacetylases 61 myo inositol 61 squamous cell lung cancer 61 estrogen receptor alpha 61 HER2 positivity 61 plasma leptin 61 inhibitory receptor 61 hematological parameters 61 NMDAR 61 selective modulator 61 CXCL5 61 FDG uptake 61 RUNX3 61 microdeletion 61 costimulatory 61 N Myc 61 peptide receptor 61 Mutational 61 tHcy 61 IL 1ß 61 alternatively spliced 61 monocytic 61 Androgen receptor 61 SOD2 61 single nucleotide polymorphism 61 hormone receptor status 61 apolipoprotein E 61 p# MAPK 61 interferon γ 61 Jurkat cells 61 VEGF receptor 61 TMEM#B 61 ALK inhibitors 61 epitope 61 thrombospondin 61 CCR2 61 serine threonine kinase 61 alexithymia 61 RANTES 61 invasive lobular 61 SNCA 61 CIN2 + 61 melatonin receptor 61 beta carotene supplementation 61 ANCOVA 61 caveolin 61 progesterone receptor 61 HNSCC 61 dimeric 61 missense mutation 61 CXCL# 61 SLC#A# [001] 61 MGUS 61 T#I [002] 61 polyadenylation 61 PEDF 61 indel 61 KRAS mutation 61 chromosome #q 61 cisplatin resistant 61 proline rich 61 VEGFR1 61 genomewide 61 receptor antagonism 61 eIF4E 61 covariate 61 renal fibrosis 61 KRAS oncogene 61 perivascular 61 nucleolar 61 amino acid substitutions 61 GPIHBP1 61 MTT assay 61 Kaplan Meier analysis 61 Cytogenetic 61 univariate analyzes 61 FGFR4 61 CYP #D# 61 histone acetyltransferase 61 plasma pharmacokinetics 61 IgG1 61 ERK activation 61 fig. S4 61 differentially regulated 61 invasive carcinoma 61 genotypic resistance 61 myeloproliferative diseases 61 Western blotting 61 oxysterols 61 TRAF1 C5 61 inducible nitric oxide synthase 61 dopamine transporter gene 61 advanced adenomas 61 mammaglobin 61 lymphoblastoid cell lines 60 MetS 60 intergenic 60 protein encoded 60 cis regulatory 60 hyperhomocysteinemia 60 highest tertile 60 hamartomas 60 androgen receptor gene 60 allelic variation 60 monogenic 60 glycosylated 60 TGF alpha 60 NPM1 mutations 60 isoleucine 60 hierarchical clustering 60 transmembrane protein 60 clusterin 60 Her2/neu 60 HBeAg 60 OPRM1 60 Wnt beta catenin 60 colorectal adenocarcinoma 60 IGFBP2 60 NFKBIA 60 obstructive coronary artery 60 serum albumin 60 antiproliferative effects 60 ANOVA 60 COMT genotype 60 apolipoprotein A1 60 cTnI 60 ELISpot 60 PPARg 60 hnRNP 60 AT1R 60 RQ PCR 60 K#N 60 M1 muscarinic 60 annexin 60 p# Shc 60 miR #b [002] 60 prospectively defined 60 Immunohistochemical 60 LKB1 60 PARP inhibition 60 EGFR receptor 60 p# biomarker 60 dopamine D2 60 ovarian carcinoma 60 CD# expression [002] 60 LNCaP cells 60 transfected cells 60 cyclin dependent kinase inhibitor 60 Genetic variants 60 adipokines 60 MMP# 60 ectopic expression 60 serum antibodies 60 AML MDS 60 metalloprotease 60 estrone 60 HOMA IR 60 immunoglobulin G 60 sarcosine 60 calcium calmodulin dependent 60 GFAP 60 underlying pathophysiology 60 transferase 60 MnSOD 60 immunofluorescent 60 occludin 60 p#/CBP 60 upregulated 60 CCR5 delta# 60 angiographically 60 ERK pathway 60 phosphorylated tau 60 inverse agonist 60 CYP#D# gene 60 GSTM1 gene 60 EGFR TKIs 60 urothelial carcinoma 60 GTPase 60 CYP#C# [001] 60 myeloproliferative 60 TSC1 60 HOTAIR 60 antioxidant supplementation 60 VMAT2 60 transgenic mouse model 60 cytogenetic abnormalities 60 Cystatin C 60 renal cell carcinomas 60 pancreatic adenocarcinoma 60 SOCS3 60 SCN5A 60 5 lipoxygenase 60 elevated ALT 60 protein tyrosine kinase 60 BMPR2 60 bFGF 60 gene amplification 60 Protein Kinase C 60 GLI1 60 nicotinic receptor 60 RAR beta 60 humoral responses 60 histologic subtypes 60 ^ sup #m 60 euthymic patients 60 miR #a [002] 60 urinary excretion 60 heterozygote 60 biologic plausibility 60 IFN beta 60 IFN gamma 60 BALB c mice 60 variant alleles 60 macroalbuminuria 60 UCP1 60 hydroxyvitamin D concentrations 60 amino terminal 60 LRP6 60 IL #R 60 autonomic dysfunction 60 BRCA1 BRCA2 60 Logistic regression 60 splice variants 60 EGFR mutation status 60 VIPR2 60 deacetylation 60 1beta 60 Genetic variation 60 5 HT2C receptor 60 p#INK#a 60 cellularity 60 Nampt 60 chromosomal instability 60 EphA2 60 SOX9 60 HLA DR4 60 interferon IFN 60 atherosclerotic lesion 60 cyclin dependent kinase 60 paralogs 60 mutant allele 60 mosaicism 60 nAChR 60 multivariable Cox 60 kinase domain 60 homozygote 60 acyl CoA 60 bcl 2 60 Genotypic 60 HIF 1a 60 Treg cell 60 microsomal 60 PBMCs 60 alkaline phosphatase 60 osteoclastic 60 SCD1 60 esophageal carcinoma 60 nitrotyrosine 60 neoplasias 60 lymphoid cells 60 muscarinic receptor 60 TMPRSS2 ERG 60 ELISPOT 60 ApoE4 60 serum lipid 60 cytopathic 60 T#M 60 cyclin E 60 MEF2A 60 cathepsin B 60 renal cortical 60 mGluR 60 murine model 60 CD3 + 60 CD# + [001] 60 NOD mice 60 cAMP signaling 60 EGFP 60 nonnucleoside reverse transcriptase inhibitors 60 multivariate logistic regression 60 Aromatase 60 abnormal p# 60 uM 60 residual confounding 60 Multivariate logistic regression 60 cytotoxicity assays 60 CYP#B# 60 cyclic AMP cAMP 60 alpha synuclein gene 60 p# mutations 60 completely resected 60 HCV replicon 60 TP# gene 60 phenotypic variation 60 proapoptotic 60 phylloquinone 60 SPINK1 60 lymphocyte activation 60 estrogen receptor ER 60 miR #b [001] 60 histologic findings 60 isotype 60 DMT1 60 PC# cells 60 thymidine 60 Notch1 60 CR nPR 60 tumor suppressor protein 60 myeloperoxidase 60 intron 60 sCJD 60 LRAT 60 proteoglycan 60 inactivating mutations 60 nodal metastases 60 Insulin sensitivity 60 guanine nucleotide exchange 60 rheumatoid factor 60 autoantigen 60 Lymph node 60 lesional 60 striatal 60 nondiabetic patients 59 sequence homology 59 vitamin D receptor 59 GRP# 59 leukocyte adhesion 59 CHI#L# 59 narcolepsy cataplexy 59 stratifying patients 59 PIK3CA 59 Janus kinase 59 autocrine 59 p# mutation 59 Lp PLA 2 59 gp# protein [002] 59 fractional anisotropy 59 histologically 59 HLA DR 59 noncoding 59 ectodomain 59 MIF protein 59 metastatic malignant 59 bladder carcinoma 59 lymphoid 59 soluble receptor 59 differentially expressed 59 interleukin IL -# 59 microdeletions 59 BCL#A 59 SIRT2 59 5 HT1A receptor 59 pCR 59 Cytotoxic T 59 acyltransferase 59 beta globin gene 59 VNTR 59 biochemical recurrence 59 clinico pathological 59 chromosomal regions 59 serine threonine 59 BRAF mutations 59 bivariate 59 IL8 59 intraperitoneally 59 oxytocin receptor 59 phospholipase A2 59 invasive carcinomas 59 CCR9 59 apoE 59 osteocalcin 59 ERa 59 acetylcholine receptor 59 S. cerevisiae 59 IGF2 59 statistically significant correlation 59 predisposing factor 59 MMP9 59 membrane proximal 59 homodimers 59 genes differentially expressed 59 metaplasia 59 extracapsular extension 59 Raf MEK ERK 59 multiple linear regression 59 LDL receptor 59 metastatic lymph nodes 59 CHD5 59 MDR1 59 apo B 59 BCL2 59 RNA binding 59 diabetes mellitus DM 59 Oncogenic 59 tumor antigen 59 serous ovarian cancer 59 adrenocortical 59 NPY gene 59 CpG 59 multivariate analysis 59 pro angiogenic 59 HLA DR4 immune 59 c myc 59 tumor necrosis 59 Genotypes 59 NRTI resistance 59 autosomal 59 Aâ 59 IL#R 59 gene rearrangements 59 SE alleles 59 BDNF gene 59 Sjögren syndrome 59 thyroid peroxidase 59 bone morphogenic protein 59 Serum concentrations 59 siRNA knockdown 59 Supplementary Fig 59 androgen independent 59 bivariate analysis 59 IgA deficiency 59 NMIBC 59 mineralocorticoid receptor 59 nAChRs 59 telomere lengths 59 APOA5 59 perilipin 59 adipogenesis 59 succinate dehydrogenase 59 mouse xenograft models 59 PTEN gene 59 p#Kip# 59 histologic 59 LDLR 59 clonal expansion 59 motor neuron degeneration 59 cyclooxygenase 2 59 methylated DNA 59 RIP1 59 catechol O methyltransferase COMT 59 fig. S1 59 antitrypsin 59 PI3K AKT 59 oligomerization 59 genetic variants associated 59 metalloproteinase 59 CHD7 59 unmeasured confounders 59 serum lipid levels 59 independent prognostic marker 59 hyperplastic 59 colonic mucosa 59 DLC1 59 surrogate markers 59 gastric carcinogenesis 59 fig. S# 59 macrophage infiltration 59 IFN g 59 PDE#A 59 prognostic biomarker 59 c myc gene 59 abnormal glucose metabolism 59 CP CPPS 59 HBeAg negative 59 receptor gene 59 IgG4 59 Kaplan Meier curve 59 N telopeptide 59 tipranavir ritonavir 59 coronary stenosis 59 acute humoral rejection 59 Univariate 59 C. albicans 59 troponins 59 ALDH2 59 59 Estrogen Receptor 59 paraoxonase 59 T2 lesions 59 HMGA2 59 cytoplasmic domain 59 osteopontin 59 secretory phospholipase A2 sPLA2 59 Orthostatic hypotension 59 selective agonists 59 relapsed MM 59 APOE allele 59 proinflammatory cytokine 59 plasma folate 59 HG PIN 59 aberrant activation 59 GPI anchored 59 constitutively 59 subgroup analyzes 59 DRD2 gene 59 glycosyltransferase 59 Karayiorgou 59 F FLT 59 statistically significant correlations 59 HDL2 59 hypothalamic pituitary adrenal axis 59 heterologous expression